Skip to main content

Harmony Biosciences Holdings Inc

For the period ended Jun 30, 2024. Filed Aug 6, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 6, 2024

HRMY$33.78+2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​
​Page
Part I. Financial Information3
Item 1. Financial Statements3
Condensed Consolidated Balance Sheets (Unaudited)3
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)4
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)5
Condensed Consolidated Statements of Cash Flows (Unaudited)6
Notes to Condensed Consolidated Financial Statements (Unaudited)7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations23
Item 3. Quantitative and Qualitative Disclosures About Market Risk37
Item 4. Controls and Procedures38
Part II. Other Information38
Item 1. Legal Proceedings38
Item 1A. Risk Factors40
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds40
Item 3. Defaults upon Senior Securities40
Item 4. Mine Safety Disclosures40
Item 5. Other Information40
Item 6. Exhibits41
Signatures42
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.